Showing 4961-4970 of 5059 results for "".
We Are All From Somewhere
https://practicaldermatology.com/issues/july-2025/we-are-all-from-somewhere/36504/Everyone in dermatology has a story about where it all started and where choices were made to lead to the next steps. The common themes are baby steps, gratitude, and not closing the door behind them.Journal Club: Dupilumab and Atopic March
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-dupilumab-and-atopic-march/32405/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Peter Lio, MD, discuss recent research indicating a reduced risk of atopic march in pediatric atopic dermatitis patients on dupilumab.Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. ReducedThe View from Under the Hood
https://practicaldermatology.com/issues/january-february-2025/the-view-from-under-the-hood/32967/As 2025 brings new approvals for treatments for hidradenitis suppurativa, chronic spontaneous urticaria, psoriatic arthritis, and several other diseases that need answers, this is a good time for us to remember that the most important approach to treatment starts with the right diagnosis.Current and Future Treatments
https://practicaldermatology.com/series/updates-vitiligo/current-and-future-treatments/26622/Dr. Karan Lal, a double board-certified adult and pediatric dermatologist and fellowship-trained cosmetic dermatologist with Affiliated Dermatology in Scottsdale, Arizona, talks with Practical Dermatology about the various options available today for repigmentation and treating flare-ups in vitiligoClose Up With Mikkel Østergaard, MD, PhD, DMSc
https://practicaldermatology.com/topics/close-up/close-up-with-mikkel-ostergaard-md-phd-dmsc/23941/Close Up with Eric F. Bernstein, MD
https://practicaldermatology.com/topics/close-up/close-up-with-eric-f-bernstein-md/23928/Letter to the Editor
https://practicaldermatology.com/columns/letter-to-the-editor/letter-to-the-editor-3/23917/PASI-HD: New Method for Measuring Severity in Mild to Moderate Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/pasi-hd-new-method-for-measuring-severity-in-mild-to-moderate-plaque-psoriasis/20185/Robert Higham, MPAS, PA-C, Executive Director of Clinical Development of Arcutis Biotherapeutics, discusses PASI-HD, a new measure designed to assess severity and therapeutic response in patients with mild and moderate psoriasis. PASI High Discrimination (PASI-HD) was developed to better understandFrom Hopelessness to Hope
https://practicaldermatology.com/topics/practice-management/from-hopelessness-to-hope/23657/New legislation aims to prevent physician suicide and burnout.It’s Time to Prep for New Information-Blocking Regs
https://practicaldermatology.com/topics/practice-management/its-time-to-prep-for-new-information-blocking-regs/23459/The deadline for compliance is April 5, 2021.